LV10573A - Panemiens farmaceitiska sastava iegusanai - Google Patents

Panemiens farmaceitiska sastava iegusanai

Info

Publication number
LV10573A
LV10573A LV930140A LV930140A LV10573A LV 10573 A LV10573 A LV 10573A LV 930140 A LV930140 A LV 930140A LV 930140 A LV930140 A LV 930140A LV 10573 A LV10573 A LV 10573A
Authority
LV
Latvia
Prior art keywords
attenuation
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
LV930140A
Other languages
English (en)
Other versions
LV10573B (en
Inventor
Jacques Julien Augros
Original Assignee
Sspl Sa Safe Sex Prod Licens
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sspl Sa Safe Sex Prod Licens filed Critical Sspl Sa Safe Sex Prod Licens
Publication of LV10573A publication Critical patent/LV10573A/lv
Publication of LV10573B publication Critical patent/LV10573B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
LVP-93-140A 1988-07-11 1993-02-25 Process for obtaining a pharmaceutical composition for the prevention of sexually transmitted diseases LV10573B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8809418 1988-07-11

Publications (2)

Publication Number Publication Date
LV10573A true LV10573A (lv) 1995-04-20
LV10573B LV10573B (en) 1995-08-20

Family

ID=9368330

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-140A LV10573B (en) 1988-07-11 1993-02-25 Process for obtaining a pharmaceutical composition for the prevention of sexually transmitted diseases

Country Status (38)

Country Link
US (1) US5439685A (lv)
EP (1) EP0351301B1 (lv)
JP (1) JPH0774164B2 (lv)
KR (1) KR0143231B1 (lv)
CN (1) CN1035038C (lv)
AP (1) AP108A (lv)
AR (1) AR243381A1 (lv)
AT (1) ATE97570T1 (lv)
BR (1) BR8903523A (lv)
CA (1) CA1341304C (lv)
CZ (1) CZ280722B6 (lv)
DD (1) DD283932A5 (lv)
DE (1) DE68910892T2 (lv)
DK (1) DK173527B1 (lv)
ES (1) ES2062065T3 (lv)
FI (1) FI101595B (lv)
HK (1) HK131095A (lv)
HU (1) HU206634B (lv)
IE (1) IE63115B1 (lv)
IL (1) IL90910A (lv)
LT (1) LT3754B (lv)
LV (1) LV10573B (lv)
MA (1) MA22036A1 (lv)
MD (1) MD406C2 (lv)
MX (1) MX170801B (lv)
MY (1) MY106242A (lv)
NO (1) NO178843C (lv)
NZ (1) NZ229891A (lv)
OA (1) OA09123A (lv)
PL (1) PL161848B1 (lv)
PT (1) PT91108B (lv)
RU (1) RU2065742C1 (lv)
SK (1) SK278614B6 (lv)
TN (1) TNSN89074A1 (lv)
TR (1) TR28353A (lv)
UA (1) UA26124A (lv)
YU (1) YU47899B (lv)
ZA (1) ZA895263B (lv)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02258718A (ja) * 1989-03-31 1990-10-19 Nippon Kayaku Co Ltd ペースト状基剤及び製剤
US5693769A (en) * 1991-12-13 1997-12-02 Transcell Technologies, Inc. Glycosylated steroid derivatives for transport across biological membranes and process for making and using same
US5795870A (en) * 1991-12-13 1998-08-18 Trustees Of Princeton University Compositions and methods for cell transformation
IT1255450B (it) * 1992-06-30 1995-10-31 Montefarmaco Spa Uso di acidi biliari come agenti antivirali
CA2167537A1 (en) * 1993-07-19 1995-02-02 Tsuneo Ozeki Hepatitis c virus proliferation inhibitor
DE4341139C1 (de) * 1993-12-02 1995-04-13 Upmeyer Hans Juergen Dimeticon zur Behandlung von Aphthen
US5667492A (en) * 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
US5700679A (en) * 1996-06-07 1997-12-23 Novavax, Inc. Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity
AU4214497A (en) * 1996-09-12 1998-04-02 Simon Everard Barton Composition comprising an antiviral or antibacterial agent for preventing transmission of diseases
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
US6211243B1 (en) 1999-09-22 2001-04-03 B. Ron Johnson Methods for treating cold sores with anti-infective compositions
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
ES2357474T3 (es) * 2000-03-07 2011-04-26 Rush-Presbyterian-St.Luke's Medical Center Composiciones y su uso para atrapar e inactivar microbios patógenos y espermatoziodes.
GB2415626B (en) * 2001-04-11 2006-03-08 Playtex Products Inc Use of a catamenial tampon which comprises a cationic surfactant for the treatment of vaginal malodor
GB2414394B (en) * 2001-04-11 2006-01-11 Playtex Products Inc Use of a catamenial tampon which comprises a non-ionic surfactant for the treatment of vaginal malodour
US8093446B2 (en) * 2001-04-11 2012-01-10 Playtex Products, Inc. Fibrous absorbent articles having malodor counteractant
DE50300325D1 (de) * 2003-11-03 2005-03-31 Peter-Hansen Volkmann Vaginalpflegezusammensetzung
KR101413361B1 (ko) * 2005-08-29 2014-06-27 셉시큐어,엘.엘.씨. 그람-양성 박테리아에 의해 유발되는 질병의 치료 또는예방 방법
DE102006020644A1 (de) * 2006-04-28 2007-10-31 Bayer Innovation Gmbh Antiseptikahaltige Silikonelastomere
US8409557B2 (en) 2006-09-28 2013-04-02 Clji Ip Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
US8062631B2 (en) 2006-09-28 2011-11-22 Clji I.P. Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
AU2012203566B1 (en) * 2008-03-27 2013-09-12 Clji I.P. Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
KR101130754B1 (ko) 2010-06-25 2012-03-28 제일약품주식회사 난용성 트리사이클릭 유도체 화합물의 용해도가 향상된 약학적 조성물
ES2896968T3 (es) * 2010-11-12 2022-02-28 The Univ Of Utah Research Foundation Dispositivos intravaginales para el suministro controlado de lubricantes
US10426761B2 (en) 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
US8992893B2 (en) 2011-04-19 2015-03-31 Arms Pharmaceutical, Llc Method of inhibiting harmful microorganisms and barrier-forming composition therefor
CA2781379C (en) 2012-03-26 2013-09-03 Clji Ip Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
KR102399883B1 (ko) * 2021-02-09 2022-05-20 재단법인대구경북과학기술원 압출용 복합고분자 펠릿 및 이의 제조방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1161484A (en) * 1965-08-20 1969-08-13 Mediline Ag Toilet Preparation
SE353658B (lv) * 1967-06-13 1973-02-12 Dow Corning
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US3770648A (en) * 1971-07-12 1973-11-06 Bristol Myers Co Anhydrous aerosol foam
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
US4393871A (en) * 1977-06-27 1983-07-19 Vli Corporation Vaginal device
US4228797A (en) * 1978-09-25 1980-10-21 Dickey Richard P Intravaginal contraception method
ZA827582B (en) * 1981-11-06 1983-08-31 Ansell Inc Spermicidal condom
ZA828965B (en) * 1981-12-07 1984-07-25 Syntex Inc Disposable intravaginal contraceptive devices releasing 1-substituted imidazoles
DE3204124A1 (de) * 1982-02-06 1983-08-18 Bayer Ag, 5090 Leverkusen Antimykotische tampons mit hoher wirkstoff-freisetzung
AU2272883A (en) * 1982-12-22 1984-06-28 Herpes Pharmaceutical Inc. Pharmaceutical compositions of steriods for treatment of herpes simplex infections
DE3346641A1 (de) * 1983-12-23 1985-07-04 Dynamit Nobel Ag, 5210 Troisdorf Silanmodifizierte estergemische
GB8402748D0 (en) * 1984-02-02 1984-03-07 Dunlop Ltd Intravaginal device
NL8600929A (nl) * 1986-04-11 1987-11-02 Fundatech Sa Werkwijze voor het vervaardigen van een gemedicateerd wegwerp-pessarium en gemedicateerd wegwerp-pessarium.
IT1213323B (it) * 1986-08-07 1989-12-20 Crinos Industria Farmaco Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida
US4952411A (en) * 1987-02-25 1990-08-28 Trustees Of Columbia University In The City Of New York Method of inhibiting the transmission of AIDS virus
GB8706313D0 (en) * 1987-03-17 1987-04-23 Health Lab Service Board Treatment & prevention of viral infections
FR2614525B1 (fr) * 1987-04-29 1995-11-10 Jacques Augros Tampon en eponge elastique, notamment tampon vaginal
US4922928A (en) * 1988-08-17 1990-05-08 Michael Burnhill Vaginal device

Also Published As

Publication number Publication date
PT91108B (pt) 1995-01-31
AU625716B2 (en) 1992-07-16
AP108A (en) 1991-02-23
DK340289A (da) 1990-01-12
LV10573B (en) 1995-08-20
FI101595B1 (fi) 1998-07-31
IE63115B1 (en) 1995-03-22
YU47899B (sh) 1996-05-20
BR8903523A (pt) 1991-11-05
RU2065742C1 (ru) 1996-08-27
NZ229891A (en) 1991-01-29
KR0143231B1 (ko) 1998-07-15
HK131095A (en) 1995-08-24
EP0351301A3 (en) 1990-12-19
HU206634B (en) 1992-12-28
NO892826D0 (no) 1989-07-07
LT3754B (en) 1996-03-25
CN1035038C (zh) 1997-06-04
NO892826L (no) 1990-01-12
LTIP1660A (en) 1995-07-25
CN1041879A (zh) 1990-05-09
ATE97570T1 (de) 1993-12-15
PL280531A1 (en) 1990-05-28
TR28353A (tr) 1996-05-16
AR243381A1 (es) 1993-08-31
EP0351301A2 (fr) 1990-01-17
UA26124A (uk) 1999-06-07
ZA895263B (en) 1991-03-27
IL90910A (en) 1994-12-29
MD406C2 (ro) 1996-06-30
JPH0774164B2 (ja) 1995-08-09
TNSN89074A1 (fr) 1991-02-04
AU3802689A (en) 1990-01-11
FI893340A (fi) 1990-01-12
NO178843C (no) 1996-06-19
IE892218L (en) 1990-01-11
CZ423889A3 (en) 1995-12-13
HUT50445A (en) 1990-02-28
CA1341304C (fr) 2001-10-09
KR900001366A (ko) 1990-02-27
DK340289D0 (da) 1989-07-10
DE68910892T2 (de) 1994-05-05
SK423889A3 (en) 1997-11-05
JPH02167235A (ja) 1990-06-27
MX170801B (es) 1993-09-14
DE68910892D1 (de) 1994-01-05
PT91108A (pt) 1990-02-08
CZ280722B6 (cs) 1996-04-17
AP8900133A0 (en) 1989-10-31
IL90910A0 (en) 1990-02-09
NO178843B (no) 1996-03-11
FI893340A0 (fi) 1989-07-10
YU135789A (en) 1992-05-28
PL161848B1 (pl) 1993-08-31
OA09123A (fr) 1991-10-31
EP0351301B1 (fr) 1993-11-24
DD283932A5 (de) 1990-10-31
MY106242A (en) 1995-04-29
ES2062065T3 (es) 1994-12-16
DK173527B1 (da) 2001-01-29
US5439685A (en) 1995-08-08
SK278614B6 (en) 1997-11-05
FI101595B (fi) 1998-07-31
MA22036A1 (fr) 1991-10-01

Similar Documents

Publication Publication Date Title
LV10573A (lv) Panemiens farmaceitiska sastava iegusanai
DK481989A (da) Farmaceutiske formuleringer
DK229489D0 (da) Laegemiddeladsorbater
DK0394026T3 (da) Formulering
FI934914A (fi) Farmaceutiska formuleringar
FR2636532B1 (fr) Compositions pharmaceutiques
DE10199066I1 (de) Pharmazeutische Zusammensetzung
KR900011476A (ko) 백신 제제
NO922005D0 (no) Farmasoeytiske preparater
NO178688C (no) Administrerings-innretning
DK489189A (da) Farmaceutisk praeparat
PT89884A (pt) Dispositivo administrador
BG91785A (bg) Лекарствена форма
DK548689D0 (da) Farmaceutisk oploesning
DK603988D0 (da) Farmaceutisk praeparat
DK496889D0 (da) Peptidholdigt farmaceutisk praeparat
MX172943B (es) Formulacion farmaceutica
PT89883A (pt) Dispositivo administrador
DK336489D0 (da) Farmaceutisk praeparat
DK0511991T3 (da) Farmaceutisk formulering
IT1227462B (it) Procedimento di preparazione di 6-ossopenicillanati
DK37589D0 (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
IT1224244B (it) Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano
GB8830405D0 (en) Pharmaceutical formulation
DK638889A (da) Farmaceutisk kombinationspraeparat